Is Autoimmune Hepatitis a Rare Disease?

Is Autoimmune Hepatitis a Rare Disease? Understanding Incidence and Prevalence

When you’re living with autoimmune hepatitis (AIH), it’s natural to wonder how common the condition is—and what it really means when doctors call something a “rare disease.” Let’s take a closer look at both questions and what current research reveals about AIH in North America and around the world.

What Does “Rare Disease” Mean?

In North America, the term “rare disease” is often used for conditions that affect a relatively small number of people compared to more common disorders. For example, in the United States, a rare disease is typically defined as one affecting fewer than 200,000 people at any given time.

While definitions can vary a little by country, the key idea is that the condition is uncommon in the general population. What many people don’t realize is that there are thousands of different rare diseases, and together they affect a significant number of people.

What Are Incidence and Prevalence?

It helps to understand two terms often used in medicine and epidemiology:

• Incidence tells us how many new cases of a disease are diagnosed in a given population over a specific period (e.g., per year).
• Prevalence tells us how many people in a population currently have the disease at a specific time (regardless of when they got it).
• For a chronic disease like AIH, where people live with the condition for many years, prevalence is often higher than the annual incidence.

How Common Is Autoimmune Hepatitis?

Research shows that AIH is indeed a rare chronic liver disease. Several recent reviews and large-scale studies provide the following insights:

• A systematic review and meta-analysis covering the years 1970–2022 found that globally, the pooled incidence of AIH was about 1.28 cases per 100,000 person-years, and the pooled prevalence was about 15.65 cases per 100,000 people. Elsevier Pure+2thelancet.com+2
• In North America (and other high-development regions), the incidence and prevalence tend to be higher than in some other parts of the world. The meta-analysis noted that incidence was greater in countries with a high Human Development Index, including North America. liu.diva-portal.org+1
• In a U.S.-based population study (2014-2019) of more than 37 million individuals, AIH prevalence was estimated at 31.2 per 100,000 people. europepmc.org
  A review in the Journal of Hepatology states that “most studies suggest an annual incidence of about 1–2 per 100,000, and a prevalence of about 20 per 100,000 in the general population (Europe, America, Asia).” journal-of-hepatology.eu

So, yes — AIH meets the criteria of a rare disease under U.S. definitions, but the numbers show it is recognized and diagnosed in thousands of people in North America.

Is Autoimmune Hepatitis Becoming More Common?

Emerging research suggests that both incidence and prevalence of AIH may be increasing, similar to trends seen in other autoimmune diseases. Some key points:

• The aforementioned meta-analysis (1970-2022) demonstrated a rise in prevalence: from about 9.95 per 100,000 in earlier decades (1970-1999) to about 27.91 per 100,000 in more recent years (2015-2022). liu.diva-portal.org+1
• A review of autoimmune liver diseases noted heterogeneous results but suggested that in North America and Europe, there appear to be increasing trends in incidence and prevalence. cghjournal.org
• As for possible reasons why such an increase might be happening, researchers point to several possibilities:
• Better awareness, improved diagnosis, and more sensitive tests (so more people are identified than in the past). Nature+1
• Environmental influences (for example, changes in exposures to pollutants or other triggers) and lifestyle factors (such as diet, obesity, and changes in gut health) may affect the immune system over time. ScienceDirect+1
• Genetic susceptibility interacting with modern environmental/lifestyle factors is a theme seen in many autoimmune conditions. Junior Chamber International+1

While the exact drivers of the increase are not yet fully understood, the research supports a genuine upward trend rather than purely an artifact of detection.

You Are Not Alone

Even though AIH is a rare disease, you are not alone. Many people in North America and around the world live with AIH. Strong patient communities, advocacy groups, and research efforts are here to support those affected by rare and autoimmune diseases. To help you navigate daily life with confidence, explore our guide on what not to do with autoimmune hepatitis.

And importantly, you are part of a larger rare-disease and autoimmune-disease community. While each condition has its own unique challenges, many share common themes and the need for support.

The Autoimmune Hepatitis Association (AIHA) recognizes the challenges and the strength of each person navigating life with AIH. Together, we can raise awareness, help each other, support ongoing research, and strengthen hope for better treatments and outcomes.

Summary: Is Autoimmune Hepatitis a Rare Disease?

• By definition, AIH is rare (but still affects many people in North America).
• Incidence refers to new cases per time; prevalence refers to how many people currently live with the disease.
• Recent data show that the incidence and prevalence of AIH are rising, likely due to a combination of better detection, environmental/lifestyle changes, and immune system factors.
• You are not isolated in your journey. There is a community, research, and growing awareness of autoimmune and rare diseases.
• If you are living with AIH, know that your voice matters, your experience counts, and together we are stronger.

Thank you for being part of the AIH community. With awareness, connection, and care, we move forward together.

Join the Autoimmune Hepatitis Association

Learn more about topics like Autoimmune Hepatitis as a Rare Disease and other aspects of living with AIH. Become a member of the Autoimmune Hepatitis Association to connect with others who understand your journey. Stay informed with the latest research updates and gain early access to educational content and event tickets.